SH
Shalby Ltd (SHALBY)
₹136.40
Mkt cap
₹1,487 Cr
P/E ratio
37.80
P/B
1.47
Div yield
0.00%
ROE
2.45%
ROCE
6.12%
EPS (TTM)
₹3.61
Book value
₹93
52W range
126–273
Sector
Healthcare
Price history
Previous close
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc. [1] The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.
NSE SHALBYBSE 540797
Health check
Cautious
ValuationCheap
ProfitabilityWeak
GrowthModerate
TechnicalsBearish
52-week range
−50.04% from high₹136
₹126+8.41% from low₹273
Current
₹136.40
Prev close
₹133.60
Day
+2.10%
Price performance
1D
+2.10%
1W
−4.78%
1M
−10.64%
3M
−21.16%
6M
−2.15%
1Y
−44.81%
YTD
−32.77%
Financials
Revenue, profit & margin
P/E ratio
37.8×
SHALBY is 24% below the sector median of 49.8×
SHALBY37.8×
Sector median49.8×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 235 | 238 | 216 | 244 | 279 | 268 | 276 | 265 | 296 | 285 | 272 | 287 | 331 | |
| Expenses | 192 | 185 | 174 | 205 | 234 | 235 | 242 | 244 | 255 | 244 | 242 | 258 | 290 | |
| Operating Profit | 43 | 53 | 42 | 39 | 45 | 33 | 34 | 21 | 42 | 42 | 30 | 29 | 42 | |
| OPM % | 18% | 22% | 20% | 16% | 16% | 12% | 12% | 8% | 14% | 15% | 11% | 10% | 13% | |
| Other Income | 5 | 5 | 5 | 5 | 10 | 7 | 5 | 5 | 7 | 4 | 7 | 8 | 7 | |
| Interest | 3 | 3 | 4 | 6 | 8 | 9 | 11 | 11 | 9 | 10 | 11 | 9 | 11 | |
| Depreciation | 12 | 12 | 12 | 16 | 16 | 17 | 16 | 16 | 17 | 17 | 18 | 18 | 19 | |
| Profit before tax | 33 | 43 | 31 | 22 | 30 | 14 | 12 | -1 | 23 | 19 | 9 | 10 | 20 | |
| Tax % | 37% | 35% | 38% | 26% | 52% | 83% | 124% | 1,547% | 66% | 62% | 86% | -92% | 47% | |
| Net Profit | 21 | 28 | 19 | 16 | 15 | 2 | -3 | -12 | 8 | 7 | 1 | 18 | 10 | |
| EPS in Rs | 1.93 | 2.55 | 1.77 | 1.54 | 1.45 | 0.31 | -0.17 | -1.02 | 0.83 | 0.78 | 0.16 | 1.70 | 1.00 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.72% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 12 Aug '26◦ |
| Earnings day | −0.72% |
| +1 day | −2.78% |
| +5 days | −1.72% |
| +15 days | −2.95% |
| +30 days | −6.46% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202674.33%Promoter
Promoters74.33%
FIIs4.47%0.11
DIIs0.30%0.05
Public20.26%0.15
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,944.50 | 61.14 | 1,28,608 | 0.22% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Max Healthcare | ₹1,049.30 | 68.21 | 1,02,129 | 0.19% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| Manipal Health | ₹738.95 | 109.77 | 97,200 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Fortis Health. | ₹886.00 | 62.70 | 66,889 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Aster DM Quality | ₹755.05 | 182.35 | 65,816 | 0.40% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Global Health | ₹1,499.40 | 70.41 | 40,315 | 0.03% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Narayana Hrudaya | ₹1,928.50 | 45.72 | 39,411 | 0.23% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| Shalby | ₹137.66 | 37.80 | 1,487 | 0.00% | 11 | +21.64% | 331 | +11.74% | 6.12% |
| Median: 30 Co. | ₹431.67 | 49.80 | 6,085 | 0.01% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Annual reports9
Concall transcripts77
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptJun 2025PPTJun 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptJul 2024PPTJul 2024TranscriptJun 2024PPTJun 2024TranscriptFeb 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Change in Management 12 Sep - Shanay Vikram Shah’s Whole-time Director appointment failed at AGM; he ceased as Additional Director on September 10, 2026.Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 11 Sep - At September 10, 2026 AGM, resolutions 3 and 4 on Shanay Vikram Shah’s appointment were not passed.Shareholder Meeting / Postal Ballot-Outcome of AGM 10 SepWeblink Letter To Shareholders Whose Email Ids Are Not Registered Intimating Exact Path Of Annual Report FY 2025-26 And Notice Of 22Nd AGM 20 Aug - Shalby shares FY26 annual report link and schedules 22nd AGM on 10 September 2026.Announcement under Regulation 30 (LODR)-Earnings Call Transcript 19 Aug - Transcript of Earnings Call held on August 13, 2026